Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 9035-9040

  Vesanen, Mika ^a   Stevens, Cladd E ^b   Taylor, Patricia E ^b   Rubinstein, Pablo ^b   Saksela, Kalle ^a,c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK BLOOD CENTER   (United States)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SEROCONVERSION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0029914177     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.9035-9040.1996     Document Type: Article

References (27)

1. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
2. Centers for Disease Control and Prevention. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adults and adolescents. Morbid. Mortal. Weekly Rep. 41:1-19.
3. Daar, E., T. Moudgil, R. Meyer, and D. Ho. 1991. Transient high levels of viremia in patients with primary human immunodeficiency virus type I infection. N. Engl. J. Med. 324:961-964.
4. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellet, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dawton, and J. Mills. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
5. Folks, T. M., K. A. Clouse, J. Justement, A. Rabson, E. Duh, J. H. Kehrl, and A. S. Fauci. 1989, Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365-2368.
6. + T-cell number decline in human immunodeficiency type 1-infected individuals. J. Virol. 69:2092-2100.
7. Graziosi, C., G. Pantaleo, L. Butini, J. Demarest, M. Saag, G. Shaw, and A. Fauci. 1993. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc. Natl, Acad. Sci. USA 90:6405-6409.
8. Harrer, E., T. Harrer, S. Buchbinder, D. L. Mann, M. Feinberg, T. Yilma, R. P. Johnson, and B. D. Walker. 1994. HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res. Hum. Retroviruses 2:S77-S78.
9. Henrard, D. R., J. F. Phillips, L. R. Muenz, W. A. Blattner, D. Wiesner, E. Eyster, and J. J. Goedert. 1995. Natural history of HIV-1 cell-free viremia. JAMA 274:554-558.
10. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
11. Hogervorst, E., S. Jurriaans, F. de Wolf, A. van Wijk, A. Wiersma, M. Valk, M. Roos, B. van Gemen, R. Coutinho, F. Miedema, and J. Goudsmit. 1995. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J. Infect. Dis. 171:811-821.
12. Huang, Y., L. Zhang, and D. D. Ho. 1995. Characterization of nef sequences in long-term survivors of human immunodeficiency type 1 infection. J. Virol. 69:93-100.
13. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Absence of intact Nef sequences in a long-term nonprogressing survivor of HIV-1 infection. N. Engl. J. Med. 332:228-232.
14. Lang, W., H. Perkins, R. E. Andersen, R. Royce, N. Jewell, and W. Winkelstein, Jr. 1989. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J. Acquired Immune Defic. Syndr. 2:63-69.
15. Lee, T. H., H. W. Sheppard, M. Reis, D. Dondero, D. Osmond, and M. P. Busch. 1994. Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J. Acquired Immune Defic. Syndr. 7:381-388.
16. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
17. Mellors, J. W., C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
18. Michael, N. L., T. Mo, A. Merzouki, M. O'Shaughnessy, C. Oster, D. S. Burke, R. R. Redfield, D. L. Birx, and S. A. Cassol. 1995. Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J. Virol. 69:1868-1877.
19. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein, C. Fox, L. K. Schrager, J. B. Margolick, S. Buchbinder, J. Giorgi, and A. S. Fauci. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209-216.
20. Rinaldo, C., X.-L. Huang, Z. Fan, M. Ding, S. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995 High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected lung-term nonprogressors. J. Virol. 69:5838-5842.
21. Saksela, K., E. Muchmore, M. Girard, P. Fultz, and D. Baltimore. 1993. High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. J. Virol. 67:7423-7427.
22. + lymphocytes. Proc. Natl. Acad. Sci. USA 91:1104-1108.
23. Saksela, K., C. E. Stevens, P. Rubinstein, P. E. Taylor, and D. Baltimore. 1995. HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS. Ann. Intern. Med. 123:641-648.
24. Stevens, C. E., P. E. Taylor, E. A. Zang, J. M. Morrison, E. J. Harley, S. Rodriguez de Cordoba, C. Bacino, R. C. Y. Ting, A. J. Bodner, M. G. Sarngadharan, R. C. Gallo, and P. Rubinstein. 1986. Human T-cell lymphotropic virus-III infection in a cohort of homosexual men in New York City. JAMA 255:2167-2172.
25. Szmuness, W., C. E. Stevens, E. J. Harley, E. A. Zang, W. R. Oleszko, D. C. William, R. Sadovsky, J. M. Morrison. and A. Kellner. 1980. Hepatitis B vaccine: demonstration of efficiency in a controlled clinical trial in a high risk population. N. Engl. J. Med. 303:833-841.
26. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency type 1 infection. Nature (London) 373:117-122.
27. Weiss, R. A. 1993. How does HIV cause AIDS? Science 260:1273-1279.